ReCode Therapeutics raised $210M Series B venture round, led by Cystic Fibrosis Foundation.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$584M
Top Valuation
-
ReCode Therapeutics raised $210M in a Series B round.
The round was announced on 01/10/23.
The round was led by Cystic Fibrosis Foundation.